2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
Jul 09, 2018G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel
Jun 08, 2018G1 Therapeutics Announces Appointment of New Members to the Board of Directors
Jun 02, 2018G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 03, 2018G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update
May 01, 2018G1 Therapeutics to Present at UBS Global Healthcare Conference in May 2018
Apr 26, 2018G1 Therapeutics to Provide First Quarter 2018 Corporate and Financial Update on May 3, 2018
Apr 16, 2018G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer
Apr 09, 2018G1 Therapeutics to Present Preclinical Data on CDK4/6 Inhibitors Trilaciclib and G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting
Mar 12, 2018G1 Therapeutics Announces Closing of Offering of Common Stock
Mar 07, 2018G1 Therapeutics Announces Pricing of Offering of Common Stock
Mar 05, 2018G1 Therapeutics Announces Proposed Offering of Common Stock
Mar 05, 2018G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer
Mar 01, 2018G1 Therapeutics to Present at Investor Conferences in March 2018
Feb 21, 2018G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
Feb 14, 2018G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018
Jan 02, 2018G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference